Added to YB: 2023-05-02
Pitch date: 2023-05-02
TPST [bullish]
Tempest Therapeutics, Inc.
-88.87%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Tempest Therapeutics, Inc., a clinical-stage oncology company, develops small molecule therapeutics that combine both tumor-targeted and immune-mediated mechanisms to treat various tumors.
Market Cap
$27.9M
Pitch Price
$27.95
Price Target
N/A
Dividend
N/A
EV/EBITDA
-0.33
P/E
-0.41
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
TEMPEST THERAPEUTICS INC TPST
A summary for this pitch has not been created yet.
Read full article (0 min)